2021
DOI: 10.12998/wjcc.v9.i36.11369
|View full text |Cite
|
Sign up to set email alerts
|

Difficulties in diagnosing anorectal melanoma: A case report and review of the literature

Abstract: BACKGROUND Anorectal melanoma is a tumour that is difficult to identify due to its rarity and variability of presentation. Insufficient data published in the literature do not allow for diagnostic and treatment guidelines to be established. Anorectal melanoma has the worst prognosis among mucosal melanomas and is frequently misdiagnosed by standard identification methods. CASE SUMMARY A 66-year-old woman presented with intermittent anal bleeding, pain, and tenesmus in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 37 publications
0
6
0
Order By: Relevance
“…The difference in failure and recurrence rate between the two procedures is minor at best; some studies do not show a significant advantage between the two [ 5 , 8 , 16 19 , 30 – 33 ]. In addition, less radical endoscopic mucosal resection has been described for less advanced cases [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The difference in failure and recurrence rate between the two procedures is minor at best; some studies do not show a significant advantage between the two [ 5 , 8 , 16 19 , 30 – 33 ]. In addition, less radical endoscopic mucosal resection has been described for less advanced cases [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Resection of lymph nodes is controversial, as it can increase complications [ 34 ]. The mesorectal, pelvic sidewall and inguinal lymph nodes are the most likely to be involved [ 29 ], but it is unclear whether the involvement or removal of these nodes improves the prognosis.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Patients with recurrent or metastatic disease have a median survival rate of less than 10 months. [1][2][3]…”
Section: Introductionmentioning
confidence: 99%